Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study

CONCLUSIONS: Every second patient with cancer experiences preDM or DM. It is essential to foster interprofessional collaboration and to develop evidence-based practice guidelines. A better understanding of the impact of cancer treatment on the development of preDM and DM remains critical.PMID:34129522 | DOI:10.6004/jnccn.2020.7653

Source: Journal of the National Comprehensive Cancer Network : JNCCN - June 15, 2021 Category: Cancer & Oncology Authors: Dominik J Ose Richard Viskochil Andreana N Holowatyj Mikaela Larson Dalton Wilson William A Dunson Vikrant G Deshmukh J Ryan Butcher Belinda R Taylor Kim Svoboda Jennifer Leiser Benjamin Tingey Benjamin Haaland David W Wetter Simon J Fisher Mia Hashibe Co Source Type: research